Corticosteroids for high-grade immune checkpoint inhibitor–mediated hepatitis: Is less more?

Jason J. Pan, Nataliya Razumilava

Research output: Contribution to journal › Editorial

Access to Document

@article{9866dfef9c5e493893fdd3b86a145ff6,

title = "Corticosteroids for high-grade immune checkpoint inhibitor–mediated hepatitis: Is less more?",

author = "Pan, \{Jason J.\} and Nataliya Razumilava",

note = "Funding Information: Supported by NIH K08‐DK122114‐01 and Gilead Sciences Research Scholar awards to N.R. ",

year = "2022",

month = mar,

doi = "10.1002/hep.32330",

language = "English",

volume = "75",

pages = "508--510",

journal = "Hepatology",

issn = "0270-9139",

number = "3",

}

TY - JOUR

T1 - Corticosteroids for high-grade immune checkpoint inhibitor–mediated hepatitis

T2 - Is less more?

AU - Pan, Jason J.

AU - Razumilava, Nataliya

N1 - Funding Information: Supported by NIH K08‐DK122114‐01 and Gilead Sciences Research Scholar awards to N.R.

PY - 2022/3

Y1 - 2022/3

UR - https://www.scopus.com/pages/publications/85124464545

U2 - 10.1002/hep.32330

DO - 10.1002/hep.32330

M3 - Editorial

C2 - 35007345

AN - SCOPUS:85124464545

SN - 0270-9139

VL - 75

SP - 508

EP - 510

JO - Hepatology

JF - Hepatology

IS - 3

ER -